Soutenir la recherche

Publications et ressources

Trier par :
Afficher :
1-9 sur 9

Chronic Exposure to Low Doses of Dioxin Promotes Liver Fibrosis Development in the C57BL/6J Diet-Induced Obesity Mouse Model

C Duval, Fatima TEIXEIRA-CLERC, AF Leblanc, S Touch, C Emond, M Guerre-Millo, S Lotersztajn, R Barouki, M Aggerbeck, X Coumoul,

Environ Health Perspect. 01/03/2017;125(3) : 428-436 10.1289/EHP316 07/10/2016

Macrophage autophagy protects against liver fibrosis in mice.

J Lodder, T Denaes, MN Chobert, J Wan, J El-Benna, Jean-Michel PAWLOTSKY, S Lotersztajn, Fatima TEIXEIRA-CLERC,

Autophagy 01/01/2015;11(8) : 1280-1292 10.1080/15548627.2015.1058473.

Reply: To PMID 23728734

Fatima TEIXEIRA-CLERC, S Lotersztajn,

Hepatology 01/01/2014;59(1) : 353-354 10.1002/hep.26533 30/09/2013

Autophagy: a multifaceted partner in liver fibrosis

A Mallat, J Lodder, Fatima TEIXEIRA-CLERC, R Moreau, P Codogno, S Lotersztajn,

Biomed Res Int. 01/01/2014;2014 : 869390 10.1155/2014/869390 31/08/2014

Aryl hydrocarbon receptor-dependent induction of liver fibrosis by dioxin

S Pierre, A Chevallier, Fatima TEIXEIRA-CLERC, A Ambolet-Camoit, LC Bui, AS Bats, JC Fournet, P Fernandez-Salguero, M Aggerbeck, S Lotersztajn, R Barouki, X Coumoul,

Toxicol Sci. 01/01/2014;137(1) : 114-124 10.1093/toxsci/kft236 23/10/2013

M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease.

J Wan, M Benkdane, Fatima TEIXEIRA-CLERC, S Bonnafous, A Louvet, Fouad LAFDIL, F Pecker, A Tran, P Gual, A Mallat, S Lotersztajn, C Pavoine,

Hepatology. 01/01/2014;59(1) : 130-142 10.1002/hep.26607. 20/11/2013

Cannabinoid signaling and liver therapeutics

A Mallat, Fatima TEIXEIRA-CLERC, S Lotersztajn,

J Hepatol. 01/10/2013;59(4) : 891-896 10.1016/j.jhep.2013.03.032 06/04/2013

Afficher :
1-9 sur 9